Bayforest Capital’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
Bayforest Capital's BLTE Position: Q3 2026 in Review
Bayforest Capital sold out of Belite Bio (BLTE) in Q3 2026, closing a stake of 307 shares — an estimated $47.3K sold.
Bayforest Capital first reported a position in BLTE in Q2 2026 and held it in 1 quarter. The position peaked at $47.3K in Q2 2026. 63 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Bayforest Capital reported no remaining Belite Bio position as of Q3 2026 after selling out during the quarter.
- Bayforest Capital sold 307 Belite Bio shares in Q3 2026, an estimated $47.3K.
- Bayforest Capital first reported a position in Belite Bio in Q2 2026 and held it in 1 quarter.
- Bayforest Capital's Belite Bio position peaked at $47.3K in Q2 2026.
- 63 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.